Management of the interaction between tacrolimus and nirmatrelvir/ritonavir in the treatment of COVID-19 in solid organ transplantation

被引：0
|
作者：
Leclerc, Vincent [1 ,3 ]
Sanctuaire, Alexandre [1 ]
Chateauvert, Nathalie [1 ,2 ]
机构：
[1] Pneumol Quebec Univ Laval IUCPQ UL, Inst Univ cardiol, Dept Pharm, Quebec City, PQ, Canada
[2] Pneumol Quebec Univ Laval IUCPQ UL, Inst Univ cardiol, Ctr Rech, Quebec City, PQ, Canada
[3] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin Se Foy, Quebec City, PQ G1V 4G5, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2023年 / 76卷 / 03期
关键词：
D O I：
10.4212/cjhp.3352
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：254 / 256
页数：3
相关论文
共 50 条
  • [21] Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies
    Tang, Yangming
    Li, Yue
    Song, Turun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [22] Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
    Akinosoglou, Karolina
    Schinas, Georgios
    Gogos, Charalambos
    VIRUSES-BASEL, 2022, 14 (11):
  • [23] Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?
    Kim, Haein
    Yang, Jeong-Sun
    Ko, Jae-Hoon
    Lee, Myungsun
    Lee, Joo-Yeon
    Park, Sehee
    Kim, Jun-Won
    Shin, Younmin
    Lee, Jung-Min
    Na, Yoo Jin
    Park, Byoung Kwon
    Kim, Hyungjin
    Lee, Young Ho
    Yang, Jinyoung
    Huh, Kyungmin
    Cho, Sun Young
    Kang, Cheol-In
    Chung, Doo Ryeon
    Peck, Kyong Ran
    FRONTIERS IN MEDICINE, 2022, 9
  • [24] A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19
    Tomida, Takeshi
    Itohara, Kotaro
    Yamamoto, Kazuhiro
    Kimura, Takeshi
    Fujita, Kohei
    Uda, Atsushi
    Kitahiro, Yumi
    Yokoyama, Naoki
    Hyodo, Yoji
    Omura, Tomohiro
    Yano, Ikuko
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 53
  • [25] MALIK'S DRUG-VIRUS INTERACTION: NIRMATRELVIR, RITONAVIR, AND COVID-19
    Ozaybi, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S420 - S420
  • [26] The interaction between nirmatrelvir/ritonavir and sirolimus: a case report of a kidney recipient with renal insufficiency and COVID-19
    Gong, Yinhua
    Shen, Dan
    Shi, Jinfang
    Jiang, Ye
    Gao, Jie
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2025, 53 (01)
  • [27] Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews
    Cruciani, Mario
    Pati, Ilaria
    Masiello, Francesca
    Pupella, Simonetta
    De Angelis, Vincenzo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (03) : 477 - 497
  • [28] Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19
    LeBras, Marlys
    Crawley, Alex
    Legge, Marc
    Takaya, Satchan
    Lee, Stephen
    Regier, Loren
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (08) : 546 - 549
  • [29] Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
    Reis, Stefanie
    Metzendorf, Maria-Inti
    Kuehn, Rebecca
    Popp, Maria
    Gagyor, Ildiko
    Kranke, Peter
    Meybohm, Patrick
    Skoetz, Nicole
    Weibel, Stephanie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09): : CD015395
  • [30] Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19
    Reddy, Gangireddy Navitha
    Jogvanshi, Akanksha
    Naikwadi, Sana
    Sonti, Rajesh
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (09) : 943 - 955
12345